Amy L. Billett, M.D.

Assistant Professor, Department of Pediatrics, Harvard Medical School

Associate in Medicine, Hematology-Oncology, Children's Hospital Boston

Clinical Associate, Pediatrics, Dana-Farber Cancer Institute

Contact Info

Amy Billett
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: Shields Warren G360
Phone: 617-632-5640
Fax: 617-632-4811
amy_billett@dfci.harvard.edu

Assistant

Lyndsay Szymanski
Administrative Assistant
Pediatrics
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Phone: 617-632-5640
Fax: 617-632-4811
lyndsay_szymanski@dfci.harvard.edu

DF/HCC Program Affiliation

Lymphoma and Myeloma

Research Abstract

Our clinical research focuses on improving the long-term outcome for children with Hodgkin's disease. We also are involved in defining and measuring medication error, and developing systems to prevent it. Our other research interests include relapsed acute lymphoblastic leukemia (ALL) and chemotherapy-induced nausea and vomiting.

Publications

No representative citations available.

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Amy L. Billett, M.D. Assistant Professor, Department of Pediatrics, Harvard Medical School Associate in Medicine, Hematology-Oncology, Children's Hospital Boston Clinical Associate, Pediatrics, Dana-Farber Cancer Institute Contact Info Amy Billett Dana-Farber Cancer Institute 44 Binney Street Boston, MA, 02115 Mailstop: Shields Warren G360 Phone: 617-632-5640 Fax: 617-632-4811 amy_billett@dfci.harvard.edu Assistant Lyndsay Szymanski Administrative Assistant Pediatrics Dana-Farber Cancer Institute 44 Binney Street Boston, MA, 02115 Phone: 617-632-5640 Fax: 617-632-4811 lyndsay_szymanski@dfci.harvard.edu DF/HCC Program Affiliation Lymphoma and Myeloma Research Abstract Our clinical research focuses on improving the long-term outcome for children with Hodgkin's disease. We also are involved in defining and measuring medication error, and developing systems to prevent it. Our other research interests include relapsed acute lymphoblastic leukemia (ALL) and chemotherapy-induced nausea and vomiting. Publications No representative citations available.
Site Map Site Feedback Web Privacy Policy